Michael F. Bigham
2020
In 2020, Michael F. Bigham earned a total compensation of $1.4M as Executive Chairman of the Board at Paratek Pharmaceuticals, a 39% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $375,000 |
|---|---|
| Salary | $500,000 |
| Stock Awards | $473,850 |
| Other | $24,703 |
| Total | $1,373,553 |
Bigham received $500K in salary, accounting for 36% of the total pay in 2020.
Bigham also received $375K in non-equity incentive plan, $473.9K in stock awards and $24.7K in other compensation.
Rankings
In 2020, Michael F. Bigham's compensation ranked 7,241st out of 13,090 executives tracked by ExecPay. In other words, Bigham earned more than 44.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,241 out of 13,090 | 45th |
Division Manufacturing | 3,029 out of 5,621 | 46th |
Major group Chemicals And Allied Products | 1,222 out of 2,254 | 46th |
Industry group Drugs | 1,055 out of 1,954 | 46th |
Industry Pharmaceutical Preparations | 788 out of 1,459 | 46th |
Source: SEC filing on April 23, 2021.
Bigham's colleagues
We found two more compensation records of executives who worked with Michael F. Bigham at Paratek Pharmaceuticals in 2020.